Menu
Sign In Search Podcasts Charts Entities Add Podcast API Pricing
Podcast Image

biobalancehealth's podcast

Healthcast 602 - Possible Early Complaints after the Initial Testosterone Pellet insertion – Part II

24 May 2022

Description

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog/ Most of you know that when I replace hormones for my female patients, I only use Bioidentical estradiol and Testosterone in the form of long-lasting subcutaneous pellets. I only use this type of delivery system because pellets deliver a steady supply of T and have the fewest side effects of any type of testosterone replacement. However, nothing is perfect, and it is important to know what the side effects of any treatment is.  There is no medical treatment without any side effects.  There is no medical care that I know of that does not create complaints by patients. There are several problems that occur during the first 4 months after the T pellets are inserted and usually present during the first 4-12 months of treatment. I will dedicate the accompanying Healthcast to later side effects of Testosterone pellets and what we recommend to lessen these effects. Of all the types of testosterone replacement for women, pellet replacement has fewer and less severe side effects than all other forms of testosterone for women. The later side effects include: Facial Hair and Acne Androgenic Hair Loss Voice Lowering Weight Gain For a full video describing these issues and the treatments, please go to my website biobalancehealth.com watch the videocast for #602.  This presentation will include the slides and audio explaining them. You can also go to You Tube to view the short lectures and slides about the side effects of testosterone pellets in women.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.